Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-133026
Filing Date
2023-05-03
Accepted
2023-05-03 06:05:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d424038ddefa14a.htm DEFA14A 18462
2 GRAPHIC g424038snap1.jpg GRAPHIC 4838
3 GRAPHIC g424038ss1.jpg GRAPHIC 31450
  Complete submission text file 0001193125-23-133026.txt   69747
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 23881517
SIC: 2836 Biological Products, (No Diagnostic Substances)